The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world treatment patterns and outcomes among patients with advanced NSCLC treated with amivantamab.
 
David Waterhouse
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; AVEO; AZTherapies; Bayer; Bristol-Myers Squibb; Daiichi; Eisai; EMD Serono; Exelixis; Fresenius Kabi; Gilead Sciences; Janssen Oncology; Lilly; McGivney Global Advisors; Merck; Mirati Therapeutics; Novartis; Pfizer; Sanofi; Sanofi/Regeneron; Seagen; Takeda
Speakers' Bureau - Amgen; AstraZeneca; Bristol-Myers Squibb; EMD Serono; Janssen Oncology; Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Iris Lin
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Laura Morrison
Consulting or Advisory Role - Johnson & Johnson (Inst)
 
Bruno Emond
Consulting or Advisory Role - Johnson & Johnson (Inst)
 
Marie-Hélène Lafeuille
Consulting or Advisory Role - Johnson & Johnson (Inst)
 
Yuxi Wang
Consulting or Advisory Role - Johnson & Johnson (Inst)
 
Lilian Diaz
Consulting or Advisory Role - Johnson & Johnson (Inst)
 
Patrick Lefebvre
Consulting or Advisory Role - Johnson & Johnson (Inst)
 
Dexter Waters
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson